
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6254802
[patent_doc_number] => 20100028960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Preparation of Precisely Controlled Thin Film Nanocomposite of Carbon Nanotubes and Biomaterials'
[patent_app_type] => utility
[patent_app_number] => 12/261892
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8844
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028960.pdf
[firstpage_image] =>[orig_patent_app_number] => 12261892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/261892 | Preparation of Precisely Controlled Thin Film Nanocomposite of Carbon Nanotubes and Biomaterials | Oct 29, 2008 | Abandoned |
Array
(
[id] => 9153799
[patent_doc_number] => 08586706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'Peptide vaccine using mimic molecules of amyloid β peptide'
[patent_app_type] => utility
[patent_app_number] => 12/739651
[patent_app_country] => US
[patent_app_date] => 2008-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6664
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739651 | Peptide vaccine using mimic molecules of amyloid β peptide | Oct 21, 2008 | Issued |
Array
(
[id] => 9166874
[patent_doc_number] => 08592552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Antiviral peptides from african swine fever virus which prevent the binding of the virus to DLC8'
[patent_app_type] => utility
[patent_app_number] => 12/739415
[patent_app_country] => US
[patent_app_date] => 2008-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10432
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739415
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739415 | Antiviral peptides from african swine fever virus which prevent the binding of the virus to DLC8 | Oct 19, 2008 | Issued |
Array
(
[id] => 7756720
[patent_doc_number] => 20120028910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'STORAGE-STABLE AQUEOUS OPHTHALMIC FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/681982
[patent_app_country] => US
[patent_app_date] => 2008-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9361
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028910.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681982
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681982 | STORAGE-STABLE AQUEOUS OPHTHALMIC FORMULATIONS | Oct 7, 2008 | Abandoned |
Array
(
[id] => 5270896
[patent_doc_number] => 20090074672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Tumor Boundary Imaging'
[patent_app_type] => utility
[patent_app_number] => 12/212646
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1583
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12212646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/212646 | Tumor Boundary Imaging | Sep 16, 2008 | Abandoned |
Array
(
[id] => 6495527
[patent_doc_number] => 20100286070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'AFFINITY TAG'
[patent_app_type] => utility
[patent_app_number] => 12/733591
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14311
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12733591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733591 | AFFINITY TAG | Sep 14, 2008 | Abandoned |
Array
(
[id] => 6514344
[patent_doc_number] => 20100216724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677553
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34235
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216724.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677553 | USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6535663
[patent_doc_number] => 20100204157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677566
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34082
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204157.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677566 | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6535327
[patent_doc_number] => 20100204140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677302
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33614
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677302
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677302 | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6534401
[patent_doc_number] => 20100204090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677547
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33819
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204090.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677547 | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6535651
[patent_doc_number] => 20100204156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF THYMOPENTIN AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677514
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34099
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677514
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677514 | USE OF THYMOPENTIN AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6535353
[patent_doc_number] => 20100204142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF THE PEPTIDE PHPFHLFVY (RENIN INHIBITOR) AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677356
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34144
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677356 | USE OF THE PEPTIDE PHPFHLFVY (RENIN INHIBITOR) AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6506919
[patent_doc_number] => 20100210559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'TRAP-14 AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677749
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33993
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677749
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677749 | TRAP-14 AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6535338
[patent_doc_number] => 20100204141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF BPP-B AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677317
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33918
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204141.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677317
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677317 | USE OF BPP-B AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 5285367
[patent_doc_number] => 20090099042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Reverse Two-Hybrid System for Identification of Interaction Domains'
[patent_app_type] => utility
[patent_app_number] => 12/206562
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28066
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206562 | Reverse Two-Hybrid System for Identification of Interaction Domains | Sep 7, 2008 | Abandoned |
Array
(
[id] => 11191562
[patent_doc_number] => 09422363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Synthetic apolipoprotein E mimicking polypeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/675089
[patent_app_country] => US
[patent_app_date] => 2008-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 22552
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675089
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675089 | Synthetic apolipoprotein E mimicking polypeptides and methods of use | Aug 26, 2008 | Issued |
Array
(
[id] => 10186826
[patent_doc_number] => 09216235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => 'Photoactivated crosslinking of a protein or peptide'
[patent_app_type] => utility
[patent_app_number] => 12/673400
[patent_app_country] => US
[patent_app_date] => 2008-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16965
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673400
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673400 | Photoactivated crosslinking of a protein or peptide | Aug 13, 2008 | Issued |
Array
(
[id] => 6102580
[patent_doc_number] => 20110166073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'ANTI-HYPERTENSIVE AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/671953
[patent_app_country] => US
[patent_app_date] => 2008-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7047
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166073.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671953 | Anti-hypertensive agent | Aug 6, 2008 | Issued |
Array
(
[id] => 5962329
[patent_doc_number] => 20110147218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT'
[patent_app_type] => utility
[patent_app_number] => 12/670533
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3602
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20110147218.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670533
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670533 | SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT | Jul 27, 2008 | Abandoned |
Array
(
[id] => 5324152
[patent_doc_number] => 20090062142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Methods for enhancing bacterial cell display of proteins and peptides'
[patent_app_type] => utility
[patent_app_number] => 12/220448
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19928
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12220448
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/220448 | Methods for enhancing bacterial cell display of proteins and peptides | Jul 23, 2008 | Issued |